ctDNA in Upper GI Cancers: Promise, Pitfalls, and What’s NextByRyan H. Moy, MD, PhDApril 20th 2026Liquid biopsy ctDNA reveals targets and flags residual disease in esophageal and gastric cancers, hinting at earlier relapse detection and tailored care.